1 - 25 of 104 results for author:"Welsh K." in Literature citations
Results Customize
› Repeat search in UniProtKB (31)
| Complement factor C7 contributes to lung immunopathology caused by Mycobacterium tuberculosis. Welsh K.J., Lewis C.T., Boyd S., Braun M.C., Actor J.K. Clin. Dev. Immunol. 2012:429675-429675(2012) · Mapped (1) |
| ARTS and Siah collaborate in a pathway for XIAP degradation. Garrison J.B., Correa R.G., Gerlic M., Yip K.W., Krieg A., Tamble C.M., Shi R., Welsh K., Duggineni S., Huang Z. et al. Mol. Cell 41:107-116(2011) · Mapped (4) |
| Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Sato H., Woodhead F.A., Ahmad T., Grutters J.C., Spagnolo P., van den Bosch J.M., Maier L.A., Newman L.S., Nagai S., Izumi T. et al. Hum. Mol. Genet. 19:4100-4111(2010) · Mapped (481) |
| CC chemokine receptor 5 gene polymorphisms in beryllium disease. Sato H., Silveira L., Spagnolo P., Gillespie M., Gottschall E.B., Welsh K.I., du Bois R.M., Newman L.S., Maier L.A. Eur. Respir. J. 36:331-338(2010) · Mapped (24) |
| Vaccinia virus protein F1L is a caspase-9 inhibitor. Zhai D., Yu E., Jin C., Welsh K., Shiau C.W., Chen L., Salvesen G.S., Liddington R., Reed J.C. J. Biol. Chem. 285:5569-5580(2010) · Mapped (5) |
| CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis. Sato H., Williams H.R., Spagnolo P., Abdallah A., Ahmad T., Orchard T.R., Copley S.J., Desai S.R., Wells A.U., du Bois R.M. et al. Eur. Respir. J. 35:324-330(2010) · Mapped (35) |
| XIAP mediates NOD signaling via interaction with RIP2. Krieg A., Correa R.G., Garrison J.B., Le Negrate G., Welsh K., Huang Z., Knoefel W.T., Reed J.C. Proc. Natl. Acad. Sci. U.S.A. 106:14524-14529(2009) · Mapped (22) |
| 11beta-hydroxysteroid dehydrogenases are regulated during the pulmonary granulomatous response to the mycobacterial glycolipid trehalose-6,6'-dimycolate. Abbott A.N., Guidry T.V., Welsh K.J., Thomas A.M., Kling M.A., Hunter R.L., Actor J.K. Neuroimmunomodulation 16:147-154(2009) · Mapped (3) |
| The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations. Kubistova Z., Mrazek F., Lympany P.A., Lagan A.L., Arakelyan A., Kriegova E., Welsh K.I., Kolek V., Zatloukal J., Hutyrova B. et al. Tissue Antigens 72:483-486(2008) · Mapped (26) |
| A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response. Welsh K.J., Abbott A.N., Hwang S.A., Indrigo J., Armitige L.Y., Blackburn M.R., Hunter R.L. Jr., Actor J.K. Microbiology (Reading, Engl.) 154:1813-1824(2008) · Mapped (3) |
| A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Lofgren's syndrome. Spagnolo P., Sato H., Grunewald J., Brynedal B., Hillert J., Mana J., Wells A.U., Eklund A., Welsh K.I., du Bois R.M. J. Intern. Med. 264:433-441(2008) · Mapped (309) |
| Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis. Carulli M.T., Spagnolo P., Fonseca C., Welsh K.I., duBois R.M., Black C.M., Denton C.P. J. Rheumatol. 35:839-844(2008) · Mapped (3) |
| Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Ross J.R., Riley J., Taegetmeyer A.B., Sato H., Gretton S., du Bois R.M., Welsh K.I. Cancer 112:1390-1403(2008) · Mapped (16) |
| Complement receptor 1 single nucleotide polymorphisms in Czech and Dutch patients with sarcoidosis. Mrazek F., Kvezereli M., Garr E., Kubistova Z., Kriegova E., Fillerova R., Arakelyan A., Ruven H.J., Drabek J., van den Bosch J.M. et al. Tissue Antigens 71:77-80(2008) · Mapped (26) |
| A polymorphism in the CTGF promoter region associated with systemic sclerosis. Fonseca C., Lindahl G.E., Ponticos M., Sestini P., Renzoni E.A., Holmes A.M., Spagnolo P., Pantelidis P., Leoni P., McHugh N. et al. N. Engl. J. Med. 357:1210-1220(2007) · Mapped (6) |
| HLA-DQB1 0602 allele is associated with splenomegaly in Japanese sarcoidosis. Sato H., Nagai S., du Bois R.M., Handa T., Suginoshita Y., Ohta K., Welsh K.I., Izumi T. J. Intern. Med. 262:449-457(2007) · Mapped (481) |
| TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. Jonth A.C., Silveira L., Fingerlin T.E., Sato H., Luby J.C., Welsh K.I., Rose C.S., Newman L.S., du Bois R.M., Maier L.A. J. Immunol. 179:4255-4262(2007) · Mapped (11) |
| Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Spagnolo P., Sato H., Grutters J.C., Renzoni E.A., Marshall S.E., Ruven H.J., Wells A.U., Tzouvelekis A., van Moorsel C.H., van den Bosch J.M. et al. Tissue Antigens 70:219-227(2007) · Mapped (306) |
| Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis. Spagnolo P., Sato H., Marshall S.E., Antoniou K.M., Ahmad T., Wells A.U., Ahad M.A., Lightman S., du Bois R.M., Welsh K.I. Invest. Ophthalmol. Vis. Sci. 48:3019-3025(2007) · Mapped (18) |
| Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. Karikari C.A., Roy I., Tryggestad E., Feldmann G., Pinilla C., Welsh K., Reed J.C., Armour E.P., Wong J., Herman J. et al. Mol. Cancer Ther. 6:957-966(2007) · Mapped (4) |
| TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. Sato H., Silveira L., Fingerlin T., Dockstader K., Gillespie M., Lagan A.L., Lympany P., Sawyer R.T., du Bois R.M., Welsh K.I. et al. J. Allergy Clin. Immunol. 119:687-696(2007) · Mapped (6) |
| Endothelin axis polymorphisms in patients with scleroderma. Fonseca C., Renzoni E., Sestini P., Pantelidis P., Lagan A., Bunn C., McHugh N., Welsh K.I., Du Bois R.M., Denton C.P. et al. Arthritis Rheum. 54:3034-3042(2006) · Mapped (4) |
| A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis. Abdallah A.M., Renzoni E.A., Anevlavis S., Lagan A.L., Munkonge F.M., Fonseca C., Black C.M., Briggs D., Wells A.U., Marshall S.E. et al. Int. J. Immunogenet. 33:155-161(2006) · Mapped (5) |
| Chymase gene (CMA1) polymorphisms in Dutch and Japanese sarcoidosis patients. Kruit A., Grutters J.C., Ruven H.J., Sato H., Izumi T., Nagai S., Welsh K.I., du Bois R.M., van den Bosch J.M. Respiration 73:623-633(2006) · Mapped (5) |
| Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. Samuel T., Welsh K., Lober T., Togo S.H., Zapata J.M., Reed J.C. J. Biol. Chem. 281:1080-1090(2006) · Mapped (5) |